Annual Analyst Update Presentation to Institutional Investors
Paiania, April 27, 2026 – Today, Lavipharm S.A. conducted its Annual Analyst Update in accordance with the Company’s Financial Calendar for 2026. The presentation took place at the Athens Stock Exchange and was organized by the Hellenic Fund and Asset Management Association.
In his opening remarks, Mr. Vassilis Baloumis, CFO of Lavipharm, stated: “Lavipharm is experiencing a period of strong growth, marked by improvements across all key financial metrics. Our recent initiatives further enhance our international footprint and underscore the Company’s ability to execute complex agreements and capitalize on emerging opportunities in global markets. With consistency and determination, we remain committed to advancing our strategy with the objective of creating long-term value.”